Injectable acrylic bone cements for vertebroplasty with improved properties

Current acrylic bone cements used in percutaneous vertebroplasty (PVP) have limitations in radiopacity and viscosity. While standard formulations meet some clinical requirements, they often fall short in critical properties such as visibility under imaging and ease of injection. Prior research has shown that these materials can be modified with radiopaque agents to enhance visibility during procedures. However, no prior work had resolved how different radiopaque agents and their surface treatments affect mechanical and injectability properties. This gap motivated the development of new formulations with improved performance. Existing studies have focused on general radiopacity enhancements but not on specific particle types or surface modifications. The need for injectable cements that maintain mechanical integrity while being easily deliverable through small needles remains unmet. This paper's contribution lies in systematically evaluating how radiopaque agent content and surface treatment influence key performance metrics. The findings may suggest new approaches to optimize cement formulations for PVP.

This study aimed to improve the properties of injectable poly(methyl methacrylate) bone cements used in vertebroplasty. The specific problem addressed was the lack of sufficient radiopacity and injectability in current formulations. The motivation came from clinical needs where visibility and ease of delivery are critical for successful procedures. The authors sought to evaluate how varying the amount and type of radiopaque agents, as well as their surface treatment, affects cement performance. They tested formulations with BaTiO3 or SrTiO3 particles at different concentrations. The goal was to identify optimal conditions that meet or exceed standard specifications while enhancing radiopacity and injectability. The study focused on the effects of silanation with gamma-MPS on mechanical and curing properties. The results could suggest new formulation strategies for improved surgical outcomes.

The researchers prepared two sets of bone cement formulations using either untreated or silanated BaTiO3 or SrTiO3 particles. Radiopacity was assessed by measuring the equivalent aluminum thickness. Mechanical properties included compressive strength and doughing and setting times. Injectability was evaluated by measuring the percentage of cement injected through a biopsy needle within four minutes. Curing parameters such as peak temperature and residual monomer content were also analyzed. The study compared formulations with varying radiopaque agent concentrations (10-50 wt.%). Silanation was performed using 3-(trimethoxysilyl) propyl methacrylate (gamma-MPS). The influence of particle type, content, and treatment was systematically examined. All formulations were tested against standard specifications for surgical plastics.

Formulations with at least 20 wt.% BaTiO3 or SrTiO3 achieved radiopacities equal to or greater than 2 mm of aluminum. Peak temperatures ranged from 57 to 72 degrees Celsius, and compressive strengths were between 114 and 135 MPa. Doughing and setting times met standard requirements. Injectability was measured at 75-80 wt.% of the total mass injected through a biopsy needle four minutes after mixing. Silanated particles produced cements with better mechanical properties and injectability compared to untreated particles. Residual monomer content remained within acceptable limits. The study found that both BaTiO3 and SrTiO3 improved radiopacity when used at higher concentrations. Silanation enhanced performance across multiple metrics.

The authors propose that formulations containing at least 20 wt.% of BaTiO3 or SrTiO3 meet the required radiopacity standards for surgical plastics. Silanation of these particles improved mechanical properties and injectability compared to untreated versions. The study suggests that both BaTiO3 and SrTiO3 are viable radiopaque agents when used at sufficient concentrations. The findings may suggest that silanation is a valuable modification for enhancing cement performance. The authors state that all formulations met standard specifications for compressive strength and curing parameters. They propose that injectability remained consistent across formulations, with values between 75 and 80 wt.%. The results may suggest that particle type and surface treatment are critical factors in cement design. The authors conclude that these findings could support the development of improved injectable bone cements for vertebroplasty.